Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.
| Image |  |
|---|---|
| Description | scientific article published on 25 July 2016 |
| Author/s |
author: David Ross |
| Publication date | July 25, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |